The ethics of gene therapy: balancing the risks

Area of Science:

• Biomedical Ethics
• Gene Therapy Research
• Clinical Trial Design

Background:

• Gene therapy research faces significant uncertainty regarding risks, particularly genotoxicity.
• This uncertainty is inherent in first-in-human clinical trials, necessitating careful risk-benefit assessments.

Purpose of the Study:

• To evaluate decision-making processes in gene therapy risk assessment.
• To explore ethical considerations in balancing risks and benefits for trial participants.

Main Methods:

• Analysis of ethical frameworks for risk assessment in gene therapy.
• Examination of subjective judgments in determining acceptable risk levels and participant categories.
• Consideration of patient attitudes and experiences in research decision-making.

Main Results:

• Ethical evaluation can improve risk assessment and decision-making processes.
• Subjective judgments are essential for defining acceptable risk, patient eligibility, and required certainty levels.
• Patient perspectives can meaningfully inform researcher decisions.

Conclusions:

• Ethical reflection enhances decision-making throughout gene therapy trial development and participant consent.
• Balancing risks and benefits is key to advancing gene therapy while safeguarding participant welfare.
• Improved ethical decision-making facilitates scientific progress and protects research participants.